Literature DB >> 24509269

Yield of downstream tests after exercise treadmill testing: a prospective cohort study.

Mitalee P Christman1, Marcio Sommer Bittencourt2, Edward Hulten2, Ekta Saksena3, Jon Hainer2, Hicham Skali2, Raymond Y Kwong4, Daniel E Forman4, Sharmila Dorbala2, Patrick T O'Gara4, Marcelo F Di Carli2, Ron Blankstein5.   

Abstract

OBJECTIVES: The purpose of this study was to estimate the frequency and results of downstream testing after exercise treadmill tests (ETTs).
BACKGROUND: The utility of additional diagnostic testing after ETT is not well characterized.
METHODS: We followed consecutive individuals without known coronary artery disease referred for clinical ETT at a large medical center. We measured the frequency and results of downstream imaging tests and invasive angiography within 6 months of ETT and the combined endpoint of survival free from cardiovascular death, myocardial infarction, and coronary revascularization.
RESULTS: Among 3,656 consecutive subjects who were followed for a mean of 2.5 ± 1.1 years, 332 (9.0%) underwent noninvasive imaging and 84 (2.3%) were referred directly to invasive angiography after ETT. The combined endpoint occurred in 76 (2.2%) patients. The annual incidence of the combined endpoint after negative, inconclusive, and positive ETT was 0.2%, 1.3%, and 12.4%, respectively (p < 0.001). Rapid recovery of electrocardiography (ECG) changes during ETT was associated with negative downstream test results and excellent prognosis, whereas typical angina despite negative ECG was associated with positive downstream tests and adverse prognosis (p < 0.001). Younger age, female sex, higher metabolic equivalents of task achieved, and rapid recovery of ECG changes were predictors of negative downstream tests.
CONCLUSIONS: Among patients referred for additional testing after ETT, the lowest yield was observed among individuals with rapid recovery of ECG changes or negative ETT, whereas the highest yield was observed among those with typical angina despite negative ECG or a positive ETT. These findings may be used to identify patients who are most and least likely to benefit from additional testing.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  downstream testing; exercise testing; imaging

Mesh:

Year:  2014        PMID: 24509269      PMCID: PMC4033667          DOI: 10.1016/j.jacc.2013.11.052

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  24 in total

1.  ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).

Authors:  Raymond J Gibbons; Gary J Balady; J Timothy Bricker; Bernard R Chaitman; Gerald F Fletcher; Victor F Froelicher; Daniel B Mark; Ben D McCallister; Aryan N Mooss; Michael G O'Reilly; William L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Loren F Hiratzka; Alice K Jacobs; Richard O Russell; Sidney C Smith
Journal:  J Am Coll Cardiol       Date:  2002-10-16       Impact factor: 24.094

2.  ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).

Authors:  Raymond J Gibbons; Gary J Balady; J Timothy Bricker; Bernard R Chaitman; Gerald F Fletcher; Victor F Froelicher; Daniel B Mark; Ben D McCallister; Aryan N Mooss; Michael G O'Reilly; William L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Loren F Hiratzka; Alice K Jacobs; Richard O Russell; Sidney C Smith
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

Review 3.  The new era of medical imaging--progress and pitfalls.

Authors:  John K Iglehart
Journal:  N Engl J Med       Date:  2006-06-29       Impact factor: 91.245

4.  A pretest prognostic score to assess patients undergoing exercise or pharmacological stress testing.

Authors:  Anthony Morise; Matthew Evans; Farrukh Jalisi; Rajendra Shetty; Marc Stauffer
Journal:  Heart       Date:  2007-02       Impact factor: 5.994

5.  Clinical end points in coronary stent trials: a case for standardized definitions.

Authors:  Donald E Cutlip; Stephan Windecker; Roxana Mehran; Ashley Boam; David J Cohen; Gerrit-Anne van Es; P Gabriel Steg; Marie-angèle Morel; Laura Mauri; Pascal Vranckx; Eugene McFadden; Alexandra Lansky; Martial Hamon; Mitchell W Krucoff; Patrick W Serruys
Journal:  Circulation       Date:  2007-05-01       Impact factor: 29.690

6.  ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine.

Authors:  Robert C Hendel; Daniel S Berman; Marcelo F Di Carli; Paul A Heidenreich; Robert E Henkin; Patricia A Pellikka; Gerald M Pohost; Kim A Williams
Journal:  Circulation       Date:  2009-05-18       Impact factor: 29.690

7.  The impact of confounder selection criteria on effect estimation.

Authors:  R M Mickey; S Greenland
Journal:  Am J Epidemiol       Date:  1989-01       Impact factor: 4.897

8.  Diagnostic value of the recovery time-course of st slope on exercise ECG in discriminating false-from true-positive ST-segment depressions.

Authors:  Satoru Sakuragi; Hiroshi Takaki; Atsushi Taguchi; Kazuhiro Suyama; Takashi Kurita; Wataru Shimizu; Toru Kawada; Yoshio Ishida; Tohru Ohe; Kenji Sunagawa
Journal:  Circ J       Date:  2004-10       Impact factor: 2.993

9.  Exercise thallium-201 scintigraphy and prognosis in typical angina pectoris and negative exercise electrocardiography.

Authors:  C N Bairey; A Rozanski; J Maddahi; K J Resser; D S Berman
Journal:  Am J Cardiol       Date:  1989-08-01       Impact factor: 2.778

10.  Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups.

Authors:  L J Shaw; E D Peterson; L K Shaw; K L Kesler; E R DeLong; F E Harrell; L H Muhlbaier; D B Mark
Journal:  Circulation       Date:  1998-10-20       Impact factor: 29.690

View more
  18 in total

Review 1.  Noninvasive Imaging to Evaluate Women With Stable Ischemic Heart Disease.

Authors:  Lauren A Baldassarre; Subha V Raman; James K Min; Jennifer H Mieres; Martha Gulati; Nanette K Wenger; Thomas H Marwick; Chiara Bucciarelli-Ducci; C Noel Bairey Merz; Dipti Itchhaporia; Keith C Ferdinand; Carl J Pepine; Mary Norine Walsh; Jagat Narula; Leslee J Shaw
Journal:  JACC Cardiovasc Imaging       Date:  2016-04

2.  Prognostic value of coronary CTA vs. exercise treadmill testing: results from the Partners registry.

Authors:  Michael K Cheezum; Prem Srinivas Subramaniyam; Marcio S Bittencourt; Edward A Hulten; Brian B Ghoshhajra; Nishant R Shah; Daniel E Forman; Jon Hainer; Marcia Leavitt; Ram Padmanabhan; Hicham Skali; Sharmila Dorbala; Udo Hoffmann; Suhny Abbara; Marcelo F Di Carli; Henry Gewirtz; Ron Blankstein
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-04-20       Impact factor: 6.875

3.  Role of Exercise Treadmill Testing in the Assessment of Coronary Microvascular Disease.

Authors:  Diana M Lopez; Sanjay Divakaran; Ankur Gupta; Navkaranbir S Bajaj; Michael T Osborne; Wunan Zhou; Jon Hainer; Courtney F Bibbo; Hicham Skali; Sharmila Dorbala; Viviany R Taqueti; Ron Blankstein; Marcelo F Di Carli
Journal:  JACC Cardiovasc Imaging       Date:  2021-08-18

4.  Clinical and Economic Implications of Inconclusive Noninvasive Test Results in Stable Patients With Suspected Coronary Artery Disease: Insights From the PROMISE Trial.

Authors:  Akash Goyal; Neha Pagidipati; C Larry Hill; Brooke Alhanti; James E Udelson; Michael H Picard; Patricia A Pellikka; Udo Hoffmann; Daniel B Mark; Pamela S Douglas
Journal:  Circ Cardiovasc Imaging       Date:  2020-04-09       Impact factor: 7.792

Review 5.  Value of Exercise ECG for Risk Stratification in Suspected or Known CAD in the Era of Advanced Imaging Technologies.

Authors:  Jamieson M Bourque; George A Beller
Journal:  JACC Cardiovasc Imaging       Date:  2015-11

Review 6.  Clinical decision making with myocardial perfusion imaging in patients with known or suspected coronary artery disease.

Authors:  Paul Cremer; Rory Hachamovitch; Balaji Tamarappoo
Journal:  Semin Nucl Med       Date:  2014-07       Impact factor: 4.446

7.  Anomalous origin of the coronary artery arising from the opposite sinus: prevalence and outcomes in patients undergoing coronary CTA.

Authors:  Michael K Cheezum; Brian Ghoshhajra; Marcio S Bittencourt; Edward A Hulten; Ami Bhatt; Negareh Mousavi; Nishant R Shah; Anne Marie Valente; Frank J Rybicki; Michael Steigner; Jon Hainer; Thomas MacGillivray; Udo Hoffmann; Suhny Abbara; Marcelo F Di Carli; Doreen DeFaria Yeh; Michael Landzberg; Richard Liberthson; Ron Blankstein
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2016-02-03       Impact factor: 6.875

Review 8.  Non-invasive assessment of low- and intermediate-risk patients with chest pain.

Authors:  Pelbreton C Balfour; Jorge A Gonzalez; Christopher M Kramer
Journal:  Trends Cardiovasc Med       Date:  2016-09-12       Impact factor: 6.677

9.  Beyond traditional cardiovascular risk factors: Could frailty and other morbidities explain the worse prognosis in patients undergoing pharmacologic stress?

Authors:  Patricia Rodriguez Lozano; Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2020-11-25       Impact factor: 5.952

10.  Prognostic value of vasodilator stress perfusion cardiovascular magnetic resonance after inconclusive stress testing.

Authors:  Théo Pezel; Thierry Unterseeh; Philippe Garot; Thomas Hovasse; Marine Kinnel; Stéphane Champagne; Solenn Toupin; Francesca Sanguineti; Jérôme Garot
Journal:  J Cardiovasc Magn Reson       Date:  2021-07-05       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.